Reproduction  
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS  
Journal of Reproduction and Fertility (1962) (1962) 4 131-136
DOI: 10.1530/jrf.0.0040131
Copyright © 1962 Society for Reproduction and Fertility
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CLEGG, E. J.
Right arrow Articles by FARLEY, T. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by CLEGG, E. J.
Right arrow Articles by FARLEY, T. M.

STUDIES ON THE ANDROGENIC ACTIVITY OF 9{alpha}-FLUORO-11β - HYDROXY-17-METHYLTESTOSTERONE ('ULTANDREN'). II. A COMPARISON BETWEEN THE ANDROGENIC PROPERTIES OF 'ULTANDREN' AND TESTOSTERONE PROPIONATE

E. J. CLEGG and T. M. FARLEY

Summary.:

  1. The relative potency of parenterally administered 'Ultandren' compared with testosterone propionate is approximately 1 when seminal vesicle weight is used as an index of androgenic activity.
  2. Coagulating gland weight is not a suitable indicator of male sex hormone activity for use in the bioassay of 'Ultandren'.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS  
Copyright © 1962 by the Society for Reproduction and Fertility.